Miacalcic Nasal 200 belongs to groups of medications called hypocalcemic agents, primarily indicated for the treatment of postmenopausal osteoporosis in women more than five years postmenopause when alternative therapies are unsuitable. Post-menopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period.
Miacalcic Nasal 200 contains Calcitonin, a human hormone that prevents bone breakdown and increases bone density (thickness). Thus it helps to treat osteoporosis in postmenopausal women.
Use Miacalcic Nasal 200 as prescribed by the doctor. Miacalcic Nasal 200 may cause certain side effects such as hypocalcemia, runny nose, nosebleed, sinus pain, application site reactions such as rhinitis (stuffy nose), epistaxis (nose bleeds) and other nasal symptoms, back pain, arthralgia (Joint pain) and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
Miacalcic Nasal 200 is for intranasal use only, do not inject or take it orally. Before using Miacalcic Nasal 200, inform your doctor of all your medical conditions, sensitivities, and all medications you are using. Miacalcic Nasal 200 is intended for post-menopausal women; therefore, Miacalcic Nasal 200 should not be recommended for other populations. Avoid drinking alcohol because it affects how the body absorbs calcium and vitamin D, which are essential for good bone formation.